BiochemProbe — Life Science Research Reagents

INF 4E free base

INF4E is a potent NLRP3 inflammasome inhibitor.

For research use only. Not for human or veterinary use.

Purity >98% Stock Inquire

INF 4E structure

CAS No.: 88039-46-7

Download structure (.mol)

Pack sizes & pricing

Size Price SKU Stock
50 mg USD 480.00 BP-02456-50mg In stock Get quote
100 mg USD 770.00 BP-02456-100mg In stock Get quote
250 mg USD 1,540.00 BP-02456-250mg In stock Get quote
500 mg USD 2,460.00 BP-02456-500mg In stock Get quote
1 g USD 3,930.00 BP-02456-1g In stock Get quote
2 g Inquire BP-02456-2g In stock Inquire

Need another size or custom synthesis? Request a quote.

Description

INF4E is a potent NLRP3 inflammasome inhibitor. INF4E inhibits caspase-1 and NLRP3 ATPase activities. INF4E shows protection against the IR-induced myocardial injury and dysfunction .

Biological activity

In Vitro INF4E (compound 9) preventes both ATP- and nigericin-triggered pyroptosis of human THP-1 cells in a time- and concentration-dependent manner. In Vivo INF4E significantly reduces the in infarct size and lactate dehydrogenase release and improvement in postischemic left ventricular pressure. INF4E attenuates the formation of NLRP3 inflammasome complex was induced by myocardial IR (ischemia/reperfusion) in a time-dependent way.

Identifiers

SMILES
CCOC(C(C(O)C1=C(Cl)C=CC=C1)=C)=O
InChIKey
BSRPDXCMAOIUOO-UHFFFAOYSA-N

Specifications

MW (average)
240.6830
Formula
C12H13ClO3
CAS No.
88039-46-7
Physical state
Liquid
Color
Colorless to light yellow
Shipping
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage
Powder -20°C, 3 years , 4°C, 2 years ; In solvent -20°C, 1 month;

Solubility

Soluble in DMSO

References

[1]. Shi Y, et al. NLRP3 inflammasome inhibitor INF39 attenuated NLRP3 assembly in macrophages. Int Immunopharmacol. 2021 Mar;92:107358.
[2].Mezzaroma E,et al. NLRP3 Inflammasome Inhibitors in Cardiovascular Diseases. Molecules. 2021 Feb 12;26(4):976.
[3].occo M, et al. Electrophilic warhead-based design of compounds preventing NLRP3 inflammasome-dependent pyroptosis. J Med Chem. 2014 Dec 26;57(24):10366-82.

Same research area

Search Inflammation/Immunology

Recently viewed